Equibles does not estimate personal net worth.
Sheila Gujrathi was last confirmed as Board Member and CEO at Gossamer Bio, Inc. (GOSS) in a filing dated April 27, 2020. The proxy statement of Gossamer Bio, Inc. reports total compensation of $7,213,742 for Sheila Gujrathi in fiscal 2020, including a base salary of $494,000. Disclosed compensation is on record for 3 fiscal years. Sheila Gujrathi has spoken on 2 earnings calls across 1 company, most recently for Gossamer Bio, Inc. on November 10, 2020. The companies whose calls Sheila Gujrathi spoke on are classified in the Healthcare sector.
“We appreciate you taking the time to hear about the progress Gossamer has made. Earlier this afternoon, Gossamer Bio was pleased to announce its financial results from the third quarter 2020 in addition to several updates to the status of our pipeline of clinical product candidates.”
“Earlier this afternoon, Gossamer Bio was pleased to announce its financial results from the first quarter 2020, in addition to several favorable updates to our pipeline of clinical product candidates.”
Start not stated–2020-04-27
Last confirmed by a filing; no departure on record
Start not stated–2020-04-27
Last confirmed by a filing; no departure on record
GOSS
Biotechnology · Healthcare
Board Member, CEO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Gossamer Bio, Inc. (GOSS) | Former President and Chief Executive Officer | $494,000 | $7,213,742 |
| 2019 | Gossamer Bio, Inc. (GOSS) | Former President and Chief Executive Officer | $515,398 | $6,245,606 |
| 2018 | Gossamer Bio, Inc. (GOSS) | Former President and Chief Executive Officer | $469,601 | $18,709,912 |
